To develop new processes to manufacture novel, conjugated-immunochemical products for life science researchers to improve fundamental research into cancer, cell biology and immunology.

To bring novel, uniquely-validated research antibodies to scientists worldwide, improve quality standards in the industry, and advance research into Alzheimer’s Disease, neurodegeneration, stroke and epilepsy.